Of note, breast cancer cell lines with PTEN loss (CAMA-1, BT-549 and ZR-75-1) were not sensitive to RNMT inhibition, suggesting that PIK3CA mutations, rather than PTEN loss, promotes RNMT dependency in breast cancer. Here, RNMT is linked to breast carcinoma.